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Abstract
Microglia, the principal neuroimmune sentinels of the brain, continuously sense changes in their
environment and respond to invading pathogens, toxins and cellular debris. Microglia exhibit
plasticity and can assume neurotoxic or neuroprotective priming states that determine their
responses to danger. We used direct RNA sequencing, without amplification or cDNA synthesis,
to determine the quantitative transcriptomes of microglia of healthy adult and aged mice. We
validated our findings by fluorescent dual in-situ hybridization, unbiased proteomic analysis and
quantitative PCR. We report here that microglia have a distinct transcriptomic signature and
express a unique cluster of transcripts encoding proteins for sensing endogenous ligands and
microbes that we term the “sensome”. With aging, sensome transcripts for endogenous ligand
recognition are downregulated, whereas those involved in microbe recognition and host defense
are upregulated. In addition, aging is associated with an overall increase in expression of
microglial genes involved in neuroprotection.
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tMicroglia, the principal resident immune cells of the brain, constitute 5–12% of brain cells
depending on the region studied 1. They are important in homeostatic functions in the brain,
in host defense against infectious pathogens and in neurodegenerative diseases and traumatic
brain injury 2. The role of microglia as mononuclear phagocytes has been recognized for
decades and their involvement in inflammatory and necrotizing processes are beginning to
be elucidated 3.
In the past decade we witnessed an explosion of work to understand the role of microglia in
the developing, healthy, aging, and diseased brain. Seminal work showed that a major
function of these cells is to constantly survey their environment sensing any changes in that
environment and responding to them 4. The genes that encode the microglial sensing
apparatus are not defined.
Microglia, like other mononuclear phagocytes such as macrophages, exhibit plasticity and
can assume neuroprotective or neurotoxic phenotypes 5–7. In advanced stages of
neurodegenerative disorders like Alzheimer’s disease, multiple sclerosis and amyotrophic
lateral sclerosis, microglia become neurotoxic 7–9. Microglia also exhibit various priming
states that determine their responses to subsequent injury or infection of the brain. Two of
these priming states include the classical priming state which occurs in response to
stimulation with Interferon-γ , and the alternative priming state associated with exposure of
these cells to Interleukin (IL) 4 or IL138, 10, 11. Classically-primed mononuclear phagocytes
are neurotoxic whereas alternatively-primed cells promote axonal elongation and sprouting
and are considered neuroprotective 8, 12.
Aging dramatically affects the gene expression profile of the brain 13. Transcriptome
profiling of the whole brain using microarrays found downregulation of genes involved in
energy production, protein synthesis and protein transport with aging and upregulation of
many genes that regulate proliferation 14. Studies looking at aging-associated changes in
individual cells have been limited 15 and quantitative changes that occur in the microglial
transcriptome with aging have not been defined.
Several approaches to analyze the transcriptomes of tissues and cells have been developed.
These include quantitative PCR (qPCR) 16, microarrays 17, 18, Nanostring™ 19 technology
and deep sequencing (RNA-Seq) 20. Valuable information can be obtained from each of
these approaches. While qPCR and Nanostring are quantitative, they are limited by the
number of transcripts that can be measured. Microarrays are very useful, but only provide a
semi-quantitative assessment of the transcriptome. aAvailable RNA-Seq platforms are
quantitative and provide a snapshot of the transcriptome of cells at a specific time point, but
vary in their requirements of the amount of RNA as a starting material and require
generation of cDNA and amplification if the sample size is small 21. Because the number of
microglia that can be harvested is limited, we were interested in an approach that utilizes
small amounts of RNA, that does not require cDNA synthesis or amplification, and that
gives robust quantitative results.
To analyze the transcriptome of microglia, we selected a recently developed technology,
Direct RNA Sequencing or DRS, because it allows the quantification of mRNA without the
need for amplification or cDNA synthesis 22 thereby providing several advantages over
existing techniques. Essentially, poly(A) mRNA is hybridized to a surface coated with
poly(dT), unbound RNA (non mRNA) is washed away and the remainder of the poly(A) tail
is blocked, followed by sequencing as described in supplementary methods. Using this
approach, we determined the unbiased quantitative transcriptome of microglia isolated from
adult 5-month old mice and compared it to that of peritoneal macrophages isolated from the
same mice and to whole brain. The datasets generated allowed us to identify a cluster of
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tgenes that constitute the microglia sensing apparatus, which we term “sensome”. We also
identified a unique microglial signature that distinguishes them from macrophages.
Furthermore, we determined changes that occur in the microglial transcriptome and sensome
during normal aging using microglia isolated from 24-month old animals. With aging, the
microglial overall gene expression profile shows an upregulation of genes involved in host
defense and neuroprotection. Our dataset is the first quantitative transcriptome of normal
microglia in adulthood and aging.
RESULTS
In order to have a standardized source of cells we used C57BL6 mice obtained from the
national Institute of Aging mouse colony (NIA, Bethesda MD). Microglia were isolated
from 5-months old adult mice by enzymatic digestion, as previously described 7, and
peritoneal macrophages were isolated by peritoneal lavage 23. Cells were stained with
fluorescent antibodies to CD11b and CD45, two well established microglia and macrophage
markers 2, 24 and supplementary Figure 1a). Microglia and macrophages were subsequently
isolated by Fluorescence Activated Cell Sorting (FACS) and RNA was extracted.
Supplementary Figure 1b-c displays the CD11b/CD45 expression patterns used to collect a
distinct population of microglia (high CD11b, low-to-intermediate CD45 2, 24) and
peritoneal macrophages (high CD11b and high CD45).
Identification of the microglial Sensome by DRS
We performed DRS on RNA isolated from whole brain (3 samples from 2 mice each) and
microglia isolated from 3 pools comprising 22, 10 and 20 mice respectively. We developed
programs in MolBioLib to annotate the various sequences obtained 25 and then analyzed the
data via GSEA 26 and edgeR27 A total of 21025 different coding transcripts were detected
(Supplementary Figure 1d). To standardize data presentation and allow comparison between
different datasets we computed the data for each transcript as copies of mRNA per million
mapped reads (CMMR).
Microglia processes constantly move in the area surrounding the cell body sensing any
changes in the environment 4. Such changes could be caused by microbial invasion, cell
injury or death associated with neurodegeneration, deposition of neurotoxic substances such
as amyloid β  23, 28 or inflammatory molecules such as chemokines and cytokines. Additional
milieu alterations could include changes in pH, in the composition or integrity of the
extracellular matrix or in extracellular metabolites such as nucleotides or amino acids. A
large armamentarium of proteins and receptors may be used by a given cell for sensing such
changes in the environment. The full spectrum of the cellular receptors and proteins used by
microglia for this purpose are not known. In this paper we define these proteins as the
“Sensome” of microglia.
We used the DAVID 29 Gene Ontology (GO) analysis software as well as manual annotation
and data mining through PubMed.gov to identify candidate sensome genes, regardless of
their level of expression. These potential sensome genes included all transmembrane
proteins and receptors, such as integrins, purinoceptors, lectins, transporters and CD
antigens, but not genes encoding for secreted proteins or proteins expressed only in nuclear,
mitochondrial or endoplasmic reticulum membranes. This analysis resulted in identifying
1299 candidate sensome genes.
To identify the transcripts that are highly enriched in microglia vs. whole brain, we
computed the ratio:   and calculated Log2E values, then selected the
top 100 transcripts with the highest E values. These transcripts are the most likely transcripts
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tto be microglia specific (Figure 1a, b and Supplementary table 1). The E value for these 100
transcripts ranged from 36 to 292. Of these transcripts 46% have an E value ≥100 indicating
a high level of enrichment in microglia (p<0.00001) (Figure 1a, b and supplementary table
1). In contrast, the E values for neuronal genes such as gamma enolase (Neuron-specific
enolase NSE), Internexin and Thy1 were 0.0018, 0.0028 and 0.0018, respectively. Similarly
the E value for the oligodendrocyte genes myelin-oligodendrocyte glycoprotein (MOG) and
chondroitin sulfate proteoglycan 4 (NG2) were 0.026 and 0.17 respectively. Furthermore,
the E value for the astrocyte markers glial fibrillary acidic protein (GFAP) and aldehyde
dehydrogenase family 1 member L1 (AlDH1L1) were 0.012 and 0.042 respectively (Figure
1c). These data indicate a high level of enrichment of microglia specific sensome genes and
a “derichment” of genes expressed by neurons and other non-microglial cells of the neural
environment in our purified microglia.
We used gene ontology analysis to classify the sensome transcripts into pattern recognition
receptors (25%), chemoattractant and chemokine receptors (10%), Fc receptors (7%),
purinergic receptors (8%), receptors for extracellular matrix (ECM) proteins (6%), cytokine
receptors (10%), receptors involved in cell-cell interaction (10%), other receptors or
transporters (13%) and potential sensome proteins with no known ligands (11%)
(Supplementary Figure 1e and Supplementary table 1). Some of the receptors identified
were expected considering that microglia have macrophage-like functions. These include
CD11b, CD14, CD68, TLR2 and TLR7, CXCL16, various Fc receptors, and others.
Interestingly, 32% of transcripts of the microglial Sensome have not been previously
described in microglia. These include Entpd1, Tgfbr2, Cmtm7, Ly86, CD180, Slco2b1,
Gi24, and Clec4a2, a complete list of these transcripts is highlighted in green in
Supplementary table 1.
These data comprehensively identify, for the first time, the armamentarium of genes used by
microglia in sensing their environment. The diversity of the ligands recognized by the
surface proteins encoded by these genes provides strong evidence that support the broad role
for microglia in homeostasis, host defense and response to injury. Of note, two of these
sensome genes, TREM2 and CD33, were recently identified as risk factors for Alzheimer’s
disease30–33, further attesting to the importance and relevance of our dataset.
To identify known and potential protein-protein interactions relevant to the sensome, we
used the STRING 9.1 software and database 34. STRING quantitatively integrates protein
interaction data from multiple sources for a large number of organisms, and transfers
information between these organisms where applicable. The database currently covers
5,214,234 proteins from 1133 organisms. Using STRING we found that 44/100 sensome
proteins have direct or indirect association with DAP12, an adaptor that regulates signaling
via TREM2 35. Of these, 24 proteins appear to have direct association with DAP12 (Figure
1d). These proteins are Trem2, P2ry6, Fcer1g, Fcgr3, Fcgr1, Fcgr4, Clec4a3, Clec5a,
Clec7a, Selplg, Csf1r, Cd14, Cd48, Cd52, Cd53, Cd68, Cd84, Cd86, Ly86, Itgb2, Tlr2,
Ptprc, Emr1 and Il10ra. These data indicate that DAP12 may be an important regulator of
the microglial sensing function through direct and indirect interaction with other sensome
proteins.
Microglia vs. Macrophages
Both microglia and macrophages are resident tissue mononuclear phagocytes and share
several functions including phagocytosis, production of reactive oxygen and nitrogen
species, response to chemokines and purinergic stimuli 36. To identify similarities and
differences between resting microglia and macrophages we used DRS to compare the
transcriptome of peritoneal macrophages with that of microglia isolated from the same mice,
and analyzed as described in the materials and methods. We compared the top 10% of
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ttranscripts with the highest expression on macrophages with those of microglia (Figure 2a).
Of these 2102 transcripts, microglia and macrophages share 1476 transcripts indicating
significant similarities between the two cell types (Figure 2a). Microglia and macrophages,
however, also have significant differences in their transcriptomes and each express 626
transcripts that are not common to the other cell (Figure 2a). The heatmap shown in figure
2b clearly defines the set of transcripts that are unique to microglia and macrophages.
Analysis of the top 25 transcripts uniquely expressed in microglia show expression levels
ranging from 360–10,088 CMMR (Figure 2c). These transcripts are highly enriched
compared to macrophages (p<0.00001, Log2 fold change ranging from 4.8–15.1)
(Supplementary Table 2). These genes include several of the Sensome genes discussed
above such as P2ry12 and P2ry13, Tmem119, Gpr34, Siglech, Trem2 and Cx3cr1 (Figure 2c
and Supplementary Table 2). In addition, microglia highly express several unique transcripts
that would not be expected to be expressed only in these cells. These include the enzyme
Hexosaminidase B (HexB) and the antimicrobial peptides Camp and Ngp (Figure 2c and
Supplementary table 2). The levels of expression of the top 25 transcripts unique to
macrophages range from 596–15,327 CMMR (Figure 2d and Supplementary table 2,
p<0.00001 for all included transcripts) with a Log2 fold change of 6.1–13.6, indicating a
high level of enrichment regardless of the copy number of each transcript (Supplementary
table 2). Macrophage-enriched genes include fibronectin, the chemokine Cxcl13, and the
endothelin B receptor (Figure 2d and Supplementary Table 2).
To identify microglial sensome transcripts that are also expressed in macrophages, we
compared expression of these genes in the two cell types. Sensome genes that are expressed
in both microglia and macrophages include Csfr1, CD53, Selplg, Fcgr3. Some microglial
sensome genes have higher expression in macrophages. These include Itgam, CD74, Emr1,
Itgb2, CD37, Clec7a, Cmklr1, Ifitm6, Pilra and Fcgr4. Interestingly, of the 22 sensome
genes that are exclusively expressed on microglia, 16 genes interact with endogenous
ligands rather than with pathogens (Figure 3a, b and Supplementary Table 2). These data
imply that microglia express a unique set of genes, distinct from macrophages, that allow
them to sense and interact with their local environment.
To further characterize the similarities and differences between macrophages and microglia
we compared the levels of expression of several specific gene families involved in immune
responses, including purinergic receptors (P2y and P2x), chemokine receptors, Fc receptors,
Interferon-inducible transmembrane (Ifitms), Toll-like receptors (Tlrs), Sialic acid binding
immunoglobulin lectins (Siglecs) and scavenger receptors (Figure 3c-j, Supplementary
Figure 2 and Supplementary Table 2). These data show that microglia express significantly
higher levels of several sensome genes that include P2rx7, P2ry12, P2ry13, P2ry6, Ccr5,
Cx3cr1, Cxcr4, Cxcr2, Tlr2, Siglech and Siglec3 compared to macrophages (all p<0.00001).
In contrast, macrophages express significantly higher levels of P2rx4, Ccr1, Cxcr7, Ifitm 2,
3 and 6 and Tlr8 (all p<0.00001). Notably, microglia express negligible levels of all Ifitms
compared to macrophages.
Because DRS data is unbiased and quantitative, comparison of the transcriptomes of whole
brain, microglia and macrophages allows us to identify a distinct gene signature for
microglia and provide a more concrete molecular definition of these cells. Each signature
includes a variety of genes with a wide range of functions. For ease of presentation, we have
graphed the top 44 of these genes, their microglial and macrophage CMMR values, fold
enrichment over brain (Log2FC) in supplementary figure 3. These genes not only reflect
unique functional capabilities of microglia, but can also be used as microglial markers to
identify these cells in physiologic conditions. Changes in expression levels of these genes
under pathologic conditions could also be used as potential biomarkers for such conditions.
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To confirm that microglial sensome genes are only expressed in microglia and not in other
brain cells, we performed dual RNAscope, a dual fluorescent in situ hybridization
technique 37. We used CD11b as a universal microglial marker and 3 microglial sensome
genes P2ry12, Cx3cr1, and P2ry6 with high, intermediate and low expression in microglia,
respectively (Figure 1a, b and Supplementary Table 1). P2ry12, Cx3cr1 and P2ry6 mRNA
co-localize with CD11b mRNA in the brain parenchyma of young mice (Figure 4a–c).
Ninety eight percent of cells expressing CD11b also express P2ry12 and Cx3cr1 and 87%
also express P2ry6 (Figure 4d). Cells that do not express CD11b mRNA did not hybridize
with probes for P2ry12, Cx3cr1 or P2ry6. These data support our DRS findings that
microglial sensome genes are exclusively expressed in microglia in the brain.
An unexpected finding revealed by our DRS analysis is that HexB is highly enriched in
microglia compared to brain (Supplementary Figure 3a). To determine if HexB is
predominantly expressed in microglia in situ, we performed dual RNAscope on mouse
brains using probes for CD11b and HexB. As observed for P2ry12, Cx3cr1 and P2ry6,
HexB mRNA also co-localizes with CD11b in the cortex, hippocampus and cerebellum
(Figure 4e). Nearly all cells expressing CD11b also express HexB (Figure 4e, f). Cells that
do not express CD11b mRNA did not hybridize with probes for HexB (Figure 4e and not
shown). These data support our finding that HexB mRNA is exclusively expressed in
microglia in the brain.
Proteomic analysis of microglia and macrophages
To determine if levels of mRNA transcripts compare with protein expression, we evaluated
protein expression differences between microglia and macrophages by two dimensional
difference gel electrophoresis (2D-DIGE), as described in materials and methods, and
compared the results with DRS data for the proteins identified. Protein samples were
extracted from each cell type and labeled with CyDye (microglia in red and macrophages in
green), mixed and loaded onto the same 2D-electrophoresis gel. Red protein spots
represented microglia-enriched proteins, green spots represented macrophage-enriched
proteins and yellow spots represented proteins expressed in both cell types (Figure 5a). To
insure unbiased analysis, we randomly selected 30 spots of interest (15 green and 15 red)
excised them from the gel and protein ID was determined via mass spectrometry. As an
example of such analysis we show one protein labeled in green (Figure 5a, Spot 10, Padi4)
and one protein labeled red (Figure 5a Spot 27, Fascin). Three dimensional graphs of the
levels of each protein expression in both cell types are shown in Figure 5b–c. The mRNA
level for each of these proteins (CMMR) was obtained from our DRS data set. Protein and
mRNA levels of both Padi4 and Fascin exhibited similar trends in expression (Figure 5d–e).
Of the 30 proteins identified, 22 exhibited similar tends of expression between protein and
mRNA levels (Supplementary Figure 4 and not shown). In the remaining 8 of the 30
proteins identified, significant differences were observed in the mRNA levels between
microglia and macrophages but not in the protein levels (not shown). An advantage of this
approach is that it allows the unbiased comparison between protein and mRNA levels since
protein identification is made after the spots are selected. A limitation of this approach is
that it only allows assessment of proteins that are intracellular or membrane proteins that are
resistant to the proteases collagenase and dispase, the two enzymes we used to purify
microglia. Nonetheless, our data show that expression levels of a majority of the proteins
identified correlate with their respective mRNA levels, thereby providing added validation
for our DRS analysis.
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We further validated our DRS data by quantitative PCR (qPCR) using a new cohort of
animals. Microglia and macrophages from thirty 5 months old mice were isolated as
described above for DRS and divided into 5 and 6 pools, respectively. We then performed
qPCR analysis on 7 transcripts including HexB, CX3CR1, P2ry12, P2ry13, P2ry6, TREM2
and CD11b. As seen in our DRS analysis, HexB, CX3CR1, P2ry12, P2ry13, P2ry6, TREM2
were highly expressed on microglia compared to macrophages (Figures 2a and 3a–b). In
contrast CD11b is more expressed on macrophages than microglia (Supplementary Figure
1). We compared qPCR and DRS data by quantifying the Log2 of the ratio of microglia/
macrophages. Figure 5f shows that the results obtained from qPCR and DRS are highly
comparable indicating that our DRS data is strongly supported by qPCR data on a different
set of mice. These results further confirm the validity of our DRS data.
Effects of aging on the microglial biological pathways
Aging is associated with significant alteration in the gene expression profile of the whole
brain 38. To determine the effects of aging on the microglia transcriptome, we used DRS to
identify the transcriptome of microglia isolated from 24-month old mice and compared it to
that of microglia isolated from 5-month old mice as described above. We limited the
analysis to transcripts expressed at ≥ 1CMMR. Of these 10,598 transcripts, 3503 transcripts
were significantly different between young and old microglia (p<0.05), 1831 were
upregulated, 1672 were downregulated and the remainder were not significantly changed in
old vs. young (Figure 6a). We performed Gene set enrichment analysis (GSEA) (see
supplementary methods) to identify pathways that are differentially changed in aging
microglia. An interesting trend emerged from our analysis. Several pathways that have been
described in the literature as promoting neurotoxicity appear to be down-regulated in aging.
In contrast, pathways involved in neuroprotection appear to be upregulated. An example of
such analysis is shown in figure 6b and supplementary figures 7–8. Genes involved in Stat
339 and Neuregulin-140 pathways are up-regulated in aging mice while those associated with
oxidative phosphorylation 41 pathways are down regulated.
Effects of Aging on the microglial priming state
Microglia exhibit various priming states that determine their responses to subsequent injury
or infection of the brain. Interferon-γ  induces microglia to assume the classical priming
state, which is associated with a neurotoxic phenotype promoting neuronal degeneration. In
contrast, the alternative priming state, associated with exposure of these cells to IL4 or IL13,
is neuroprotective and promotes axonal sprouting and elongation 8, 12. Each priming state is
characterized by increased expression of a defined set of genes that regulate microglial
behavior and are considered markers for the corresponding priming state 11.
To determine the effect of aging on the microglial priming state we compared expression of
classical and alternative priming genes 10, 42 in microglia isolated from 5 months vs. 24
months old mice. We found that in microglia from 24 months old mice, expression of
alternative priming markers ranged between 6–348 CMMR and classical priming markers
were expressed between 4 and 105 CMMR (Supplementary Table 3). Sixty-two percent
(23/37) of alternative priming markers were significantly upregulated in microglia from
aged mice (Mean Log2Fold change = 1.97, p<0.012), while 32% (12/37) were not
significantly changed and only CD302 and TGFβ 1 were down-regulated (Figure 7a and
Supplementary table 3). In contrast, aging was associated with downregulation or no change
in 7/12 (58%) of the classical priming state markers (Mean Log2FC=0.37) (Figure 7b and
Supplementary Table 3). These data suggest that during aging there is a shift of the
microglial phenotype towards an alternative neuroprotective priming state.
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82% (18/22) of inflammasome genes included in our analysis were either significantly
downregulated or not significantly changed (Figure 7c and Supplementary table 3). Because
upregulation of some inflammasome genes such as NLRP3 have been implicated in the
pathogenesis of Alzheimer’s disease 43 these findings further support that during normal
aging there is a shift of the microglial phenotype towards an alternative neuroprotective
priming state.
Effects of aging on the microglial sensome
We also assessed any age-related changes in the microglial Sensome genes and in selected
families of genes. We found that 31% (31/100) of the Sensome genes are significantly
downregulated with aging (p<0.043), and 13% were significantly upregulated with aging
(P<0.008) (Figure 8a and Supplementary table 3). Remarkably, 81% of the genes that were
significantly downregulated (25/31 genes) encoded proteins involved in sensing endogenous
ligands, while 62% (8/13) of the genes that were upregulated encoded proteins involved in
sensing infectious microbial ligands (Figure 8a and Supplementary tables 1 and 3). Genes
that were significantly downregulated encoded for proteins involved in sensing apoptotic
neurons (Trem2, p<0.00005), substances released following neuronal injury such as
nucleotides and adenosine and molecules expressed in the cell surface (siglech, p=0.003 and
Dap12, p=0.00005) and soluble cytokines (Ccr5, p=0.0006 and Ifngr1, p=0.00033). Genes
that were significantly upregulated encoded proteins involved in sensing of bacterial and
fungal ligands (Tlr2, CD74, Ltf, Clec7a, Cxcl16 and Ifitm6, all p≤0.0006) or bacterial toxins
(C5ar1, p<0.00005) (Figure 8a–i and supplementary tables 1 and 3).
Among the chemokine receptors, Cxcr4 and Cxcr2 were significantly (p≤0.0001) increased
in aged microglia (Figure 8e and Supplementary table 3). Of note, there were significant
changes in expression of members of the Ifitm family of innate immune receptors.
Significant increases were seen in Ifitm2, 3 and 6 (Figure 8g, and Supplementary table 3 all
p≤0.0001).
DISCUSSION
The data presented in this manuscript fill several major gaps in our understanding of
microglia. First, the use of direct RNA sequencing allowed us to generate a quantitative
dataset of the normal adult microglia transcriptome, representing an accurate snapshot of
these cells’ gene expression profile. This is the only such dataset available at this point for
any cell type of the mammalian brain. Our dataset avoids the potential pitfalls associated
with other approaches to study gene expression because it does not involve cDNA synthesis
or amplification. Our data also differ from semi-quantitative datasets since we provide copy
numbers of each transcript rather than relative arbitrary units, allowing the possibility to
compare with similar datasets generated in the future. The ability to perform such a
comprehensive study using small amounts of unamplified RNA provides proof of concept
that this approach can be applied to various cells from different healthy and diseased
mammalian tissues. One can envision using DRS on cells obtained from biopsy samples
providing a more personalized approach to understand gene expression profiling in the
brain. The strength of our data is highlighted by the correlation between the copy number of
each transcript obtained by DRS with in situ hybridization, with the relative protein
expression of several proteins as determined by unbiased proteomic analysis by 2D-DIGE
and mass spectrometry of 30 proteins, and by qPCR of several genes.
Second, we introduce a new area of investigation, namely that of the microglial Sensome.
We identified 100 genes that constitute the microglial toolset for sensing changes in the
brain’s milieu. Since sensing of the brain environment is a major function of microglia, our
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tdata define the apparatus that microglia use to perform these homeostatic functions
including sensing of chemokines and cytokines, purinergic molecules, inorganic substances,
changes in pH and amino acids. Defining the microglial Sensome under physiological
conditions, establishes a baseline to which we can compare and identify changes that occur
in this Sensome under pathological conditions. As an example we performed studies to
identify changes in the Sensome that occur with aging and identified significant changes as
shown above and discussed below. Defining changes in the Sensome that accompany
infection, neurodegeneration, traumatic brain injury and inherited disorders is likely to have
significant implications for identifying biomarkers, as well as novel therapeutic modalities
for such disorders 44. Highlighting the importance of our dataset, two members of the
microglial Sensome, TREM2 and CD33, have been found to be independent risk factors for
late onset Alzheimer’s disease 30–32. We propose that several additional members of the
microglial Sensome are also key players in a number of CNS disorders.
Third, because we compared the copy number of each transcript in microglia, whole brain
and macrophages, we were able to identify a molecular signature that defines microglia and
distinguishes these cells from other types of resident macrophages and other cells in the
brain. Such analyses yielded some expected results such as the high level of expression of
the purinergic receptor P2ry12, the chemokine receptor Cx3cr1, and Trem2 the receptor for
apoptotic neurons in microglia. In addition, our data showed some very surprising and
unexpected findings. For example, we found that the enzyme hexosaminidase B (HexB) is
predominantly a microglial enzyme in the brain. The level of expression of this transcript in
microglia indicates it is one of the most expressed mRNAs in these cells. HexB mRNA is
enriched 164 fold in microglia compared to brain, more than the level of enrichment of the
quintessential microglial marker Cx3cr1 (fold enrichment 142.5) and CD11b (fold
enrichment 98.8), one of the two markers we used to identify microglia in our studies. These
data indicate that HexB is indeed a microglial gene. We further confirmed this observation
using dual RNAscope fluorescent in situ hybridization. Since HexB mutations cause the
neurodegenerative gangliosidosis Sandhoff disease 45 this finding would have significant
implications for our understanding of this disease, suggesting that this inherited disorder is
essentially a “microglia” disorder. This suggests that microglia, rather than neurons, may be
the better targets for therapeutic intervention in this disorder. This is an example of the
usefulness of our data and their potential implications for significantly altering our
understanding of microglial biology in sickness and in health. Another likely implication
from these findings is the identification of several new microglial markers. In this regard,
our data complements recent microarray data 46 and adds significantly to such data. Indeed,
32% of transcripts of the microglial Sensome have not been previously described in
microglia.
Another important result in our dataset is the finding that resting microglia express high
levels of several antimicrobial peptides not previously known to be expressed on these cells.
These include Camp, the cathelin-related antimicrobial peptide (633 CMMR) and Ngp the
neutrophilic granule protein (424 CMMR). The high level of expression of these peptides
indicates a high level of readiness by the normal “quiescent” resident microglia to perform
its innate host defense function in the absence of adaptive immune molecules and cells.
Fourth, we identified several age-related changes in the microglial transcriptome. For
example, the microglial Sensome is significantly altered in aging. More than 81% of
Sensome genes that were downregulated in aging are involved in sensing endogenous
ligands. Of particular interest are purinergic and associated receptors such as P2yr12,
P2ry13 and Adora3, and receptors recognizing apoptotic neurons and other cells such as
Siglech. Purinergic molecules are released with neuronal injury and cell death, events that
are likely to increase with aging. The continuous stimulation of microglia that could result
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tfrom excessive neuronal injury and death that accompany aging, may initiate a cycle of
events that leads to further microglial-mediated neurotoxicity adding “insult to injury”. It is
therefore conceptually beneficial to the brain to downregulate the ability of microglia to get
activated by dying or injured cells with aging. Interestingly, sensing genes involved in
phagocytosis such as CD11b, CD14, ICAMs and CD68 are unchanged suggesting that the
ability to clear endogenous debris is not affected. Similarly, genes that mediate the ability of
microglia to sense microbial ligands are either not affected or increased. These data contrast
with what happens in advanced stages of neurodegenerative disorders like Alzheimer’s
disease, multiple sclerosis and amyotrophic lateral sclerosis, where microglia become
neurotoxic 7–9. These data also contrast with recent findings of neurotoxic aging associated
changes in the peripheral immune system 47. Our data suggest that with aging, there is a
shift in the microglial phenotype towards a more neuroprotective type. While the peripheral
immune system may become more primed towards a neurotoxic state 47, our data suggest
that the microglia maintains its ability to defend against infectious pathogens and clear
debris but attempts to “tone down” the stimulatory effects of endogenous debris as if to keep
from becoming constantly activated.
On its face our data appear to conflict with reports that suggest that aging is accompanied by
an overall increase in pro-inflammatory status of the brain 48–50. An important distinction
between these studies and ours is that they were done using whole brain tissue rather than
purified cells. Changes observed in these studies reflect not only the gene expression
profiles of microglia but of other glial cells, and possibly circulating blood leukocytes.
Furthermore, these studies either included a limited number of genes 48 or involved injecting
the brain with a cocktail of cytokines prior to gene expression analysis 50. These technical
differences may explain the differences in our results and these published reports.
In support of an aging-associated change in the microglial phenotype towards a more
neuroprotective state is our finding that several potential neurotoxic pathways such as the
oxidative phosphorylation pathway are downregulated in microglia with aging 41. In contrast
pathways that may be neuroprotective such as the STAT3 and Neuregulin-1 pathways are
upregulated. Furthermore, the microglial priming state is also altered in aging towards an
alternative phenotype. Classical and alternative priming states are not activation states but
rather priming states that dictate how the microglia will respond to a certain stimulus. In
spinal cord injury, for example, an alternative priming state is associated with improved
axonal sprouting and elongation indicating a neuroprotective phenotype 12. Genes that are
upregulated in an alternative primed state such as MRC1, Dectin and Lgals3 favor
phagocytosis of debris and pathogens. Other genes such as Arg1 and IL1rn downregulate the
innate response possibly reducing the damage associated with such a response. Arg1 induces
a shift in arginine metabolism from interferon-γ -induced NO production towards production
of ornithine and polyamine which are important in wound healing. Similarly, IL1rn
antagonizes the effects of IL1 10. Taken together our data suggest that aging is associated
with a shift in the microglial gene expression profile towards a more neuroprotective
phenotype. We propose that when the brain is faced with an injury or stimulus that acutely
activates the microglia, the alternative primed state assumed by these cells with aging may
not completely prevent the damages induced by the injurious stimuli, but will likely help
reduce the effects of such damage.
Our approach and data presented in this manuscript are a major step towards establishing a
definitive quantitative microglia transcriptome under a variety of pathological situations.
Understanding the changes that occur in the microglia in aging, neurodegeneration, infection
and traumatic injury is the first step in identifying therapeutics that modulate the state of
these cells and ultimately alter disease processes.
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tSupplementary Materials and Methods
Mice
C57Bl/6 mice 5 months and 24 months of age were purchased from the National Institute on
Aging and housed in the animal care facility at Massachusetts General Hospital and used
within two weeks of arrival. Mice were euthanized according to approved institutional
procedures. All protocols were approved by the Massachusetts General Hospital Institutional
Animal Care and Use Committee and met US National Institutes of Health guidelines for the
humane care of animals.
Isolation of peritoneal macrophages and microglia
Peritoneal macrophages—Peritoneal cells were harvested from 5-month old mice by
peritoneal lavage with 10ml phosphate buffer saline without Ca++ and Mg++ (PBS=)
containing 1 mM EDTA (PBS=/EDTA) and centrifuged at 400×g for 10 mins. The
peritoneal cells were then stained for CD11b and CD45for flow cytometry (see below). Each
sorting experiment was performed on cells pooled from 5 mice per experiment.
Microglia—Two ages of mice were used for isolation of microglia: 5 months old and 24
months old. Mice were perfused with 50cc PBS=. Brains were then removed, rinsed in PBS=
and placed separately into a GentleMacs™ C-tube (Miltenyi Biotech) with RPMI (no phenol
red) containing 2mM L-glutamine (Mediatech), Dispase (2U/ml) and 0.2% Collagenase
Type 3 (Worthington Biochemicals) according to our previous protocol 7. Brains were
processed using the gentleMACS Dissociator (Miltenyi Biotech) on the brain program
settings according to manufacturer’s directions. Briefly, the brains were subjected to three
rounds of dissociation each followed by a period of incubation at 37°C. After the second
round of dissociation, DNase I grade II (Roche Applied Science) was added to a
concentration of 40U/ml and incubated for an additional 10 minutes before the final round
of dissociation. The digestion enzymes were inactivated by addition of PBS=/EDTA
containing 5% fetal bovine serum (FBS) and the digested brain bits were triturated gently,
passed over a 100μ m filter (Fisher Scientific) and centrifuged. Cell pellets were resuspended
in 10.5 ml RPMI/L glutamine, mixed gently with 4.5 ml physiologic Percoll® (Sigma
Aldrich), and centrifuged at 850×g for 40 minutes. The resulting cells were rinsed in PBS=
and centrifuged. At this time any contaminating red blood cells were lysed using RBC lysis
buffer (Sigma) according to manufacturer’s instruction, rinsed twice with PBS= and passed
over a 40μ m filter (Fisher Scientific). Cells were then stained for CD11b and CD45 for flow
cytometry (see below). Each sorting experiment was performed on cells pooled from 5 mice
per experiment.
Staining for CD11b and CD45 and Fluorescence Activated Cell Sorting (FACS)
After isolations, cell pellets were resuspended in blocking buffer (PBS=/1mM EDTA/2%
donkey serum) containing 1ug/ml Fc block (BD Pharmingen) and incubated on ice for 10
mins. Cells were co-stained for 30 minutes on ice with Alexa-647 labeled anti-CD11b (clone
M/170, Biolegend, final conc 5 ug/ml) and Alexa488-labeled CD45 (Biolegend, clone 30-
F11, final conc 5 ug/ml). Cells were then rinsed in PBS/EDTA centrifuged, resuspended in
PBS/EDTA containing1% fetal bovine serum and filtered into 5 ml polystyrene filter top
tubes (BD Falcon) for sorting. Cells were sorted based on CD11b/CD45 expression 24 using
FACS ARIA(BD). Sorted cells were centrifuged 400×g for 10 minutes and pellets were
either lysed in RLT-Plus buffer (Qiagen) for RNA extraction or stored at −80°C for protein
extraction and proteomics analysis.
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tRNA and DRS
RNA was isolated from flow cytometry-sorted cell populations using RNeasy Plus micro/
mini kits (Qiagen) depending on cell number. For RNA from whole brains, 6 mice were
euthanized, perfused with PBS=/EDTA and brains were removed and homogenized in
Qiazol using the TissueShredder (Qiagen) and RNA isolated with RNeasy Plus Minikit
(Qiagen). Three pools of two brains per pool were created for whole brain RNA. Purified
RNAs were quantified with a Nandrop 2000 (Thermo Scientific) and the quality of the RNA
assessed using an Agilent Bioanalyzer (Agilent), all RNA used had an RNA Integrity
Number (RIN)>9.2. RNAs from each population set were pooled as needed to yield samples
containing at least 300ng of RNA. There were three pools of microglia RNA from 22, 10,
and 20 5-month old mice, three pools of RNA from 24-month old mice comprising 10 mice
per pool, and three pools of macrophage RNA that represented 10 mice each. DRS was
performed by Helicos (Cambridge, Massachusetts) using Helicos single molecule prototype
sequencers 22, 51–53. On average 14,376,408 and 19,007,620 reads were obtained from each
microglial and macrophage samples respectively. Of these, 8,480,397 reads and 11,946,274
were annotated for microglia and macrophages respectively. RNA samples that were sent to
Helicos were coded such that the identity of the cell types was not known.
RNAscope
RNA scope is a novel RNA in-situ hybridization technique that allows visualization of two
RNA biomarkers within single cells. RNAscope uses a unique probe design strategy that
results in signal amplification and background suppression 37. RNA scope was performed at
Advanced Cell Diagnostics where the technique was developed. Briefly, frozen brains from
C57Bl6 mice were cut horizontally and slices were hybridized with several dual probes sets
using CD11b conjugated to Alexa546 as the common probe in each set. The companion
probes to CD11bAlexa546were HexB, Cx3cr1, P2ry6, and P2ry12 (all conjugated to
Alexa-488) and nuclei were visualized using DAPI. The resulting hybridized brain slices
were imaged using the Mirax MIDI slide scanner to visualize the entire slice. To quantify
cells that expressed both CD11b and other genes of interest, first CD11b positive cells were
identified and annotated using Panoramic Viewer 1.15.2 software (3D Histech Limited); for
each brain slice 100 cells were counted in cortex, 100 cells in the hippocampus, and 50 cells
in the cerebellum. The number of double positive cells was then quantified. Each data point
represents mean ± SD of 2–3 brain slices for each probe set. Dual RNAscope experiments
were repeated twice on different slide sets with similar results.
Bioinformatics Analysis
Raw reads were filtered to remove low-quality reads and those that do not meet a filter
length. For each sample, Helicos provided the alignment files which also contain the query
and reference sequences. Each sample alignment file was processed individually by a
program written in MolBioLib 25 to determine which gene(s) (if any) were hit by each
alignment. The number of hits was recorded both in raw units as well as in copies per
million mapped reads [CMMR]-normalized units 54. Only the hits to the sense of the genes
are kept. The raw counts were analyzed using EdgeR 27, 55, 56 to generate p-values. EdgeR
estimates the common negative binomial dispersion by conditional maximum likelihood.
The log2 of the CMMR-normalized values were used as input to discover signatures for
class types by using the gene expression monitoring scoring system 57. Scores are sorted
with the largest score indicating genes that are most enriched in the class in question and
least enriched outside of that class. The gene set enrichment analysis was performed using
the GSEA software 26, 58 using the complete set of normalized input values, the
c2.all.v3.0.symbols.gmt curated gene set, 1000 gene permutations, and using the classes
(e.g. old versus young) as the phenotype. (The gene symbol “chip” was selected as the chip
platform.) All processing unless otherwise noted was done in the MolBioLib framework.
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calculated by EdgeR as well as student T-test were <0.05.
No statistical methods were used to pre-determine sample sizes but our sample sizes are
similar to those generally employed in the field.
Proteomics
2-D DIGE and Mass spectrometry protein identification were performed by Applied
Biomics (Hayward, CA). Proteomic analysis was done on microglial and macrophage
lysates using pooled cells isolated from 70 mice and 50 mice, respectively.
Cell lysate preparation—Frozen cell pellets were lysed in 200 ul 2-D cell lysis buffer
(30 mM Tris-HCl, pH 8.8, containing 7 M urea, 2 M thiourea and 4% CHAPS). The cells
were sonicated at 4° C, incubated on a shaker for 30 minutes at room temperature, followed
by centrifugation for 30 min at 14,000 rpm. Supernatants were collected and protein
concentrations determined by the Bio-Rad Protein Assay (Biorad). Sample lysates were
diluted with the sample 2-D cell lysis buffer to the same protein concentration of 3 to 8 mg/
ml.
Minimal CyDye labeling—To 30 ug of cell lysate, 1.0 ul of diluted CyDye (Cy2, Cy3 or
Cy5) (1:5 diluted with DMF from 1 nmol/ul stock) was added, incubated on ice for 30 min
in the dark, followed by addition of 1.0 ul of 10 mM Lysine to each of the samples and
incubation on ice in the dark for additional 15 min. Cy2, Cy3 and Cy5labeled samples were
mixed together followed by addition of 2X 2-D Sample buffer (8 M urea, 4% CHAPS, 20
mg/ml DTT, 2% pharmalytes and trace amount of bromophenol blue), and loaded onto a 13
cm IPG strip.
IEF and SDS-PAGE—After loading the labeled samples into the strip holder, IEF was run
in the dark at 20 °Caccording to protocol provided by Amersham BioSciences. Upon
finishing the IEF, the IPG strips were incubated in equilibration buffer 1 (50 mM Tris-HCl,
pH 8.8, containing 6 M urea, 30% glycerol, 2% SDS, trace amount of bromophenol blue and
10 mg/ml DTT) for 15 minutes with slow shaking. Then the strips were rinsed in
equilibration buffer 2 (50 mM Tris-HCl, pH 8.8, containing 6 M urea, 30% glycerol, 2%
SDS, trace amount of bromophenol blue and 45 mg/ml Iodacetamide) for 10 minutes with
slow shaking. The IPG strips were then rinsed once in the SDS-gel running buffer before
being transferred into the SDS-Gel (12% SDS-gel prepared using low florescent glass
plates) and sealed with 0.5% (w/v) agarose solution (in SDS-gel running buffer). The SDS-
gels were run at 15 °C and until the dye front reached the end of the gel.
Image scan and data analysis—Image scans were carried out immediately following
the SDS-PAGE using Typhoon TRIO (Amersham BioSciences) following the protocols
provided. The scanned images were then analyzed by Image QuantTL software (GE-
Healthcare), and then subjected to in-gel analysis and cross-gel analysis using DeCyder
software version 6.5 (GE-Healthcare). The ratio change of the protein differential expression
was obtained from in-gel DeCyder software analysis.
Spot picking and Trypsin digestion
The spots of interest were picked up by Ettan Spot Picker (GE Healthcare) based on the in-
gel analysis and spot picking design by DeCyder software. The gel spots were washed,
followed byin-gel digestion with modified porcine trypsin protease (Trypsin Gold,
Promega). The digested tryptic peptides were desalted by Zip-tip C18 (Millipore). Peptides
were eluted from the Zip-tip with 0.5 ul of matrix solution (α -cyano-4-hydroxycinnamic
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tacid, 5 mg/ml in 50% acetonitrile, 0.1% trifluoroacetic acid, 25 mM ammonium
bicarbonate) and spotted on the MALDI plate.
Mass Spectrometry
MALDI-TOF (MS) and TOF/TOF (tandem MS/MS) were performed on a 5800 mass
spectrometer (AB Sciex). MALDI-TOF mass spectra were acquired in reflectron positive
ion mode, averaging 2000 laser shots per spectrum. TOF/TOF tandem MS fragmentation
spectra were acquired for each sample, averaging 2000 laser shots per fragmentation
spectrum on each of the 5–10 most abundant ions present in each sample (excluding trypsin
autolytic peptides and other known background ions).
Database search
Both the resulting peptide mass and the associated fragmentation spectra were submitted to
GPS Explorer version 3.5 equipped with MASCOT search engine (Matrix science) to search
the database of National Center for Biotechnology Information non-redundant (NCBInr).
Searches were performed without constraining protein molecular weight or isoelectric point,
with variable carbamidomethylation of cysteine and oxidation of methionine residues, and
with one missed cleavage allowed in the search parameters. Candidates with either protein
score C.I.% or Ion C.I.% greater than 95 were considered significant.
Quantitative Real Time PCR
Microglia and peritoneal macrophages were isolated from a different cohort of 5-month old
mice than the ones used for DRS comprising 6 sets of 5 mice per set. The sorts resulted in 6
pools of macrophages and 5 pools of microglia. Total RNA from each sample of cells (3.0–
8.0 ×105 cells) was isolated using the RNeasy® Plus micro kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions and reverse transcribed using Multiscribe™
reverse transcriptase (Applied Biosystems, Foster City, CA). Dilutions of each cDNA prep
were used to assess β 2-microglobulin RNA levels and samples were then adjusted to give
equivalent levels of β 2-microglobulin per well in subsequent qPCR reactions for other
genes. The qPCR was performed in a Roche 480 Lightcycler qPCR machine (Indianapolis,
IN) in duplicates using SYBR Green to detect the amplification products. The following
cycles were performed: initial denaturation cycle 95°C for 10 min, followed by 40
amplification cycles of 95°C for 15 secs and 60°C for one min and ending with one cycle at
25°C for 15 secs. Relative quantification of mRNA expression was calculated by the
comparative cycle method to obtain the ratio of gene interest/B2M.
The following are genes and primers used in these experiments:
Cd11b (GTGTGACTACAGCACAAGCCG, CCCAAGGACATATTCACAGCCT)
Cx3cr1 (ACCGGTACCTTGCCATCGT, ACACCGTGCTGCACTGTCC)
HexB (ACTCCAAGATTATGGCCTCGAGCA,
AGCTATTCCACGGCTGACCATTCT)
B2M (CCGAACATACTGAACTGCTACG, CCCGTTCTTCAGCATTTGGA)
P2ry6 (CTGCGTCTACCGTGAGGATT, GCAATGACGCAGATGTTCAG)
P2ry12 (CACGGATTCCCTACACCCTG, GGGTGCTCTCCTTCACGTAG)
P2ry13 (AACAAAGCTGATGCTCGGGA, GTGTCATCCGAGTGTCCCTG)
Trem2 (GCCTTCCTGAAGAAGCGGAA, GAGTGATGGTGACGGTTCCA
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Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. The microglial Sensome identified by direct RNA sequencing
Of the 21025 transcripts measured, we used gene ontology (GO) analysis and identified
1299 potential sensome genes. Of these, we selected the top 100 transcripts with the highest
enrichment of microglia/brain and termed this gene collection as the microglial “Sensome”.
a–b. Expression levels of genes of the microglial Sensome in mRNA copies per million
reads (CMMR) in microglia and brain. Values are mean ± SD of three different experiments
done with microglia pooled from 22, 10 and 20 mice, respectively. and three pools of RNA
from 2 brains each. For differences in expression between microglia and brain p<0.00001
for all Sensome genes shown in graph. Data can be found in Supplementary Table 1. c.
Log2Fold change (graybars) of non-microglial genes specific for neurons, astrocytes and
oligodendrocytes and show “derichment” in microglia compared to whole brain. d. Network
analysis of the microglial Sensome by STRING identified a DAP12 centered pathway with
44/100 genes with direct or indirect interaction with DAP12. Of these, 24 have a direct
interaction with Dap12 and are highlighted using a largerfont.
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tFigure 2. Differences between microglia and macrophages revealed by DRS
a. Venn diagram showing similarities and differences of the top 10% of transcripts
expressed in microglia and macrophages. b. Heat map and hierarchal clustering of the
transcripts that are unique to microglia or macrophages, showing a distinct signature for
each of the cell types. c. The top 25 transcripts with the highest CMMR that are unique to
microglia have barely detectable levels in macrophages (p<0.00001 for differences between
microglia and macrophage expression). These top 25 transcripts show high level of
enrichment (Log2Fold Change >4) over macrophages regardless of the level of expression in
microglia. d. The top 25 transcripts unique to macrophages with the highest CMMR have
barely detectable levels in microglia (p<0.00001 for differences between macrophages and
microglia expression). These top 25 transcripts unique to macrophages show high level of
enrichment (Log2Fold Change >5) over microglia regardless of the level of expression in
macrophages. (Values in c–d mean ± SD of three different experiments done with
microgliapooled from 22, 10and 20 mice, respectively and three pools of macrophages from
10 mice per pool) Data for Figure 1c–d can be found in Supplementary Table 2.
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tFigure 3. Comparative expression of the microglial and macrophages genes
Comparison ofexpression levels of Sensome genes and those involved in regulating the
immune response reveal a distinct immune signature for each cell type. a, b. Expression
levels of the microglial Sensome in microglia and macrophages show that several genes are
differentially expressed. c. Purinergic P2rx receptors. d. Purinergic P2ry receptors. e.
Chemokine Ccr and Cx3cr1 receptors. f. Chemokine Cxcr receptors. g. Fc receptors. h.
Interferon-inducible transmembrane (Ifitms). i. Toll-like receptors (Tlrs) 1–13. j. Sialic acid
binding immunoglobulin lectins (Siglecs). (Values are mean ± SD of three different
experiments done with microglia pooled from 22, 10 and 20 mice, respectively and three
pools of macrophages from 10 mice per pool.) Data for Figure 3a–j can be found in
Supplementary Table 2.
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tFigure 4. RNAscope dual fluorescent in situ hybridization
Dual RNAscope was performed on brain slices from adult mice for CD11b and sensome
genes with high (P2ry12), intermediate (Cx3cr1) and low (P2ry6) levels of expression and
for the highly expressed Hexb gene. The results confirm DRS findings and show exclusive
expression in microglia and no expression in CD11b negative cells. a. Dual RNAscope for
CD11b (red) and P2ry12 (green) probes, nuclei are stained with DAPI (blue). Bottom panels
are magnified images of the double positive cells shown in the top panel. b. Dual RNAscope
for CD11b (red) and Cx3cr1 (green) probes. Bottom panels are magnified images of the
double positive cells shown in the top panel. c. Dual RNAscope for CD11b (red) and P2ry6
(green) probes. Bottom panels are magnified images of the double positive cells shown in
the top panel. d. Quantitative image analysis of RNAscope data for CD11b+ cells with
P2ry12 and Cx3cr1 and P2ry6. e. Dual RNAscope for CD11b (red) and Hexb (green) probes
in the cortex, hippocampus and cerebellum. f. Nearly all of CD11b+ cells in the cortex,
hippocampus and cerebellum, respectively, co-express HexB.
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tFigure 5. Proteomic analysis of microglia and macrophages
a. Fluorescent 2D-DIGE of microglia (labeled in red) and macrophages (labeled in green)
proteins showing common (labeled in yellow) and unique proteins for each cell type. Right
panel shows an enlarged view of the area delineated in left panel. b. quantitative diagram of
spot # 10 identified by mass spectrometry as Padi4 showing lower level of expression in
microglia compared to macrophages. c. quantitative diagram of spot # 27 identified by mass
spectrometry as fascin showing higher level of expression in microglia compared to
macrophages. d, e. Comparison of protein levels (measured by mass spectrometry) and
mRNA levels (measured by DRS) of Padi4 and fascin in macrophages and microglia. (DRS
values are mean ± SD of three different experiments done with microglia pooled from 22, 10
and 20 mice, and from three pools of macrophages from 10 mice per pool, protein values are
from pooled microglia and macrophages isolated from 70 and 50 mice, respectively). f.
Validation by qPCR of some genes obtained with DRS on new cohorts of mice. The new
cohorts comprised 5 sorted microglia pools and 6 macrophage pools from sorting of six sets
using five mice per set. Ratio values for qPCR and DRS data represent the ratio of gene of
interest to B2-micoglobulin expression. Data are plotted as log2 fold differencebetween
microglia/macrophageratio values.
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tFigure 6. Effects of Aging on the microglial mRNA expression profile
a. Heatmap of the 10598 microglial transcripts expressed at >1CMMR shows that 1831
transcripts were upregulated, 1672 were downregulated and 7095 remained unchanged with
aging. b. GSEA pathways analysis showed upregulation of potentially neuroprotective
pathways such as Stat 3 and Neuregulin-1 and downregulation of potentially neurotoxic
pathways such as oxidative phosphorylation. Each bar at the bottom of each panel represents
a member gene of the respective pathway and shows its relative location in the ranked list of
genes (lowest panel).
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tFigure 7. Upregulation of alternative priming genes in microglia from aged mice
a,b. Alternative and classical priming genes in microglia from 24 months compared with
mice 5 months of age old mice show a wide range of expression levels. a. In old mice, 24 of
37 alternative priming state markers were statistically significantly upregulated (*p<0.016).
b. In 24 months old vs. microglia from 5 months old mice, 5 of 12 markers of the classical
priming state were significantly upregulated in microglia, while the remaining 7 were down-
regulated or not significantly changed. c. Analysis of 22 inflammasome-associated genes
shows that 4 are significantly up-regulated in old mice compared with young ones
(*p<0.025), while the remaining 18 genes are down-regulated or not significantly changed.
Taken together the data suggest a trend toward increased expression of genes involved in
resolution of inflammation and neuroprotection. Values are Log2 Fold change of three
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tdifferent experiments done with microglia pooled from 22, 10 and 20 young mice,
respectively and from three pools of 10 mice per pool from old mice.. Data for this figure is
found in Supplemental Table 3.
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tFigure 8. The microglial sensome in aging
a. measurement of the Log2Fold change of genes encoding the microglial sensome as
determined by DRS show that ~81% of the genes are significantly downregulated
(Escr1→Tmem173, p<0.043) and encoded proteins involved in sensing endogenous ligands
(red bars). Of the 69 genes that are unchanged or upregulated, 45% encoded proteins
involved in sensing infectious microbial ligands (blue bars and purple bars). Of the genes
that are significantly upregulated ~62% (C3ar1→Ifitm6, p<0.008) encoded proteins
involved in pathogen sensing and host defense. b-i. Comparative expression of genes
involved in regulating the immune response in old vs. young microglia reveals a selective
set of genes that are changed with normal aging. Values are mean ± SD of three different
experiments done with microglia pooled from 22, 10 and 20 young mice, respectively and
from three pools of microglia from 10 mice per pool., * indicates p<0.03.
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